Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
 Medical News
 Blood Safety News
-NHF and Community News
 Industry News
 Travel Advisory

 

 

 
MASAC Issues Updated Treatment Document
 

The National Hemophilia Foundation’s (NHF) Medical and Scientific Advisory Council (MASAC) has issued the following updated document, which was adopted by NHF’s Board of Directors on June 13, 2013:

 

MASAC Document #217: MASAC Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorders (Revised April 2013)

The document includes:

  • Recommendations for physicians treating patients with hemophilia A and B, von Willebrand disease and other congenital bleeding disorders
  • Recommendations to manufacturers of coagulation products
  • Recommendations to the Food and Drug Administration

To view this document, click the link above or review the complete list of current MASAC documents. To request a hard copy of any current documents, please contact HANDI, NHF’s information resource center: handi@hemophilia.org or 1.800.424.2634

 

This section of our Web site is sponsored by: